| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |